美股异动丨Q2业绩超预期，吉利德科学大涨10%创历史新高

Core Viewpoint - Gilead Sciences (GILD.US) shares surged by 10%, reaching a record high of $121.38 following the release of its earnings report, which exceeded market expectations [1] Financial Performance - For Q2 2025, Gilead reported a revenue increase of 2% to $7.08 billion, surpassing market expectations of $6.98 billion [1] - The adjusted earnings per share (EPS) were $2.01, exceeding the market forecast of $1.96 [1]